• LAST PRICE
    0.0002
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0002
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0034
  • Volume
    50

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNPHC
Nutra Pharma Corp
1.5M
0.3x
---
United StatesSGBI
Sangui Biotech International Inc
1.3M
-126.8x
---
United StatesCTTH
CTT Pharmaceutical Holdings Inc
1.5M
-0.4x
---
United StatesBVXV
BiondVax Pharmaceuticals Ltd
4.9M
-0.5x
---
United StatesPBLA
Panbela Therapeutics Inc
1.7M
0.0x
---
United StatesCMXC
Cell MedX Corp
1.8M
-2.0x
---
As of 2023-01-29

Company Information

Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Its Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Its Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain in horses. Its Luxury Feet is an over-the-counter pain reliever and anti-inflammatory product, which is designed for women who experience pain or discomfort due to high heels and stilettos. It also manufactures a zeolite detoxifier, Cell Defender for a third-party distributor.

Contact Information

Headquarters
12538 W. Atlantic Blvd.CORAL SPRINGS, FL, United States 33071
Phone
954-509-0911
Fax
877-895-5647

Executives

Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
Rik Deitsch
Chief Scientific Officer
Dale Vanderputten
Director
Stewart Lonky
Director
Garry Pottruck

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5M
Revenue (TTM)
$247.8K
Shares Outstanding
7.6B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.75
EPS
$0.00
Book Value
$0.00
P/E Ratio
0.3x
Price/Sales (TTM)
6.1
Price/Cash Flow (TTM)
0.2x
Operating Margin
-592.70%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.